Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Alpha2-HS glycoprotein (AHSG), a glycoprotein present in the serum, is synthesized by hepatocytes. Additionally we are shipping Fetuin A Kits (88) and Fetuin A Proteins (44) and many more products for this protein.
Showing 10 out of 183 products:
Human Polyclonal Fetuin A Primary Antibody for EIA, IHC (fro) - ABIN115504
Arnaud, Kalabay: Alpha2-HS glycoprotein: a protein in search of a function. in Diabetes/metabolism research and reviews 2002
Show all 6 references for ABIN115504
Human Monoclonal Fetuin A Primary Antibody for ELISA, WB - ABIN393360
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010
Show all 5 references for ABIN393360
Dog (Canine) Polyclonal Fetuin A Primary Antibody for WB - ABIN2778140
Ix, Shlipak, Brandenburg, Ali, Ketteler, Whooley: Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. in Circulation 2006
Show all 2 references for ABIN2778140
Human Polyclonal Fetuin A Primary Antibody for EIA, WB - ABIN118026
Schafer, Heiss, Schwarz, Westenfeld, Ketteler, Floege, Muller-Esterl, Schinke, Jahnen-Dechent: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. in The Journal of clinical investigation 2003
Show all 2 references for ABIN118026
Human Polyclonal Fetuin A Primary Antibody for EIA, FACS - ABIN950366
Voigt, Fischer, Rimpau, Schareck, Haffner: Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. in Histopathology 2010
Show all 2 references for ABIN950366
Human Monoclonal Fetuin A Primary Antibody for IF, ELISA - ABIN1996377
Zheng, Li, Zhang, Zhou, Ma, Zhou, Chen, Lin: Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases. in Scientific reports 2014
Human Polyclonal Fetuin A Primary Antibody for IF (p), IHC (p) - ABIN681733
Naito, Hashimoto, Watanabe, Shirai, Takahashi, Kojima, Watanabe, Sato, Iso, Matsuyama, Suzuki, Ishibashi-Ueda, Watanabe: Facilitatory effects of fetuin-A on atherosclerosis. in Atherosclerosis 2016
Increased serum visfatin (show NAMPT Antibodies), fetuin-A, and PTX3 (show PITX3 Antibodies) levels, and the presence of positive correlation between visfatin (show NAMPT Antibodies), fetuin-A, and Psoriasis area and severity index, probably reflect the inflammatory state and insulin (show INS Antibodies) resistance seen in psoriasis.
peritoneal dialysis patients with heart failure have significantly lower fetuin-A levels
Study showed that serum levels of Fetuin-A are linked to serum calcium homeostasis and AHSG genotype but not with coronary artery calcification severity in subjects without coronary vasculopathy.
Serum fetuin-A concentrations are independently correlated with VEGF (show VEGFA Antibodies) and CRP (show CRP Antibodies) concentrations in T2DM patients with DR, but not in NDR (show STK38 Antibodies) subjects
From infancy to aging: Biological and behavioral modifiers of Fetuin-A.
Fetuin-A exerts the stimulatory effects on inflammatory responses in HUVECs, macrophage foam cell formation, and proliferation and collagen production in HASMCs, leading to the development of atherosclerosis.
Common variants in the AHSG gene are strongly associated with fetuin-A levels, but their concurrent association with CHD (show CHDH Antibodies) risk in current prospective studies is inconsistent
results indicated that the cis (show CISH Antibodies)-regulatory expressional difference of AHSG is expected to occur at the level of transcription or splicing of mRNA
Data suggest that serum fetuin-A (FETUA/AHSG) concentrations are signi fi cantly positively associated with serum VEGFA (vascular endothelial growth factor A (show VEGFA Antibodies)) levels in patients with newly diagnosed type 2 diabetes.
Reanalysis of a total of 47 MDS (show PAFAH1B1 Antibodies) patients revealed biomarker candidates, with alpha-2-HS-glycoprotein and leucine-rich alpha-2-glycoprotein (show LRG1 Antibodies) as the most promising candidates.
Site-specific analysis of the O-glycosylation of bovine fetuin by electron-transfer dissociation mass spectrometry.
These experiments revealed a second mechanism of long-term mineral ion stabilization by the fetuin-A that is complementary to the formation of calciprotein particles.
AHSG is produced in bone, mainly in osteocytes and also show for the first time that its production is modulated by FGF23 (show FGF23 Antibodies).
These findings establish urinary Fetuin-A as a sensitive biomarker of the progression of autosomal dominant polycystic kidney disease.
Plasma levels of the calcification inhibitor fetuin-A were significantly decreased in CKD animals compared to controls.
fetuin-A regulates endochondral ossification through mineralization inhibition and lipid (hormone) binding [review]
Our results show that CSF (show CSF2 Antibodies) fetuin-A is a biomarker of disease activity and natalizumab response in multiple sclerosis
lipid-induced FetA from adipocytes is an efficient chemokine (show CCL1 Antibodies) for macrophage migration and polarization
FetA, via its terminal galactoside moiety, directly binds Leu100-Gly123 & Thr493-Thr516 in Tlr4 (show TLR4 Antibodies), fulfilling the requirement of an endogenous ligand for TLR4 (show TLR4 Antibodies) through which lipids induce insulin (show INS Antibodies) resistance.
Our results show that fetuin-A has a developmental rather than a structural role in murine bone.
Fetuin-A-containing calciprotein particles facilitate the clearance of mineral debris by macrophages via SR-A (show MSR1 Antibodies).
ER stress induced by high glucose and palmitate increases the expression of fetuin-A and further contributes to the development of insulin (show INS Antibodies) resistance
Alpha2-HS glycoprotein (AHSG), a glycoprotein present in the serum, is synthesized by hepatocytes. The AHSG molecule consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several functions, such as endocytosis, brain development and the formation of bone tissue. The protein is commonly present in the cortical plate of the immature cerebral cortex and bone marrow hemopoietic matrix, and it has therefore been postulated that it participates in the development of the tissues. However, its exact significance is still obscure.
, 59 kDa bone sialic acid-containing protein
, alpha 2 HS-glycoprotein alpha 2 (fetuin)
, glycoprotein PP63
, phosphorylated N-glycoprotein pp63
, alpha-2-HS glycoprotein
, pre-pro polypeptide (AA -18 to -346)
, alpha2-HS glycoprotein